Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Blog | April 30, 2021

EDTX Monthly Wrap-Up — April 2021

Article | April 26, 2021

Fish & Richardson Principal Ahmed Davis Authors The National Law Journal Article, "Celebrating Black Inventors on World IP Day"

Blog | April 13, 2021

EDTX & NDTX Monthly Wrap-Up — March 2021

Blog | March 16, 2021

Extraterritorial Application of the Defend Trade Secrets Act

Blog | March 11, 2021

Preserving Trade Secrets at District Court Hearings and Trials

Blog | March 11, 2021

Legal Alert: Supreme Court Hears Oral Arguments in Arthrex

Article | March 08, 2021

Fish Attorneys Author Biosimilar Development Article, "Regulatory And Legislative Actions Set The Tone For Biosimilars In 2021"

Blog | March 02, 2021

EDTX & NDTX Monthly Wrap-Up — February 2021

Blog | February 04, 2021

Biosimilars 2020 Year in Review

Q&A | February 03, 2021

Q&A with John Hayden for Corporate Counsel Business Journal

Blog | January 29, 2021

COVID-19 Relief Coalition Selected for Boston Bar Association Beacon Awards

Article | January 26, 2021

Kurt Glitzenstein Quoted in The American Lawyer "Litigation Leaders" Article